The FDA just green-lit bemotrizinol, a UV filter that dermatologists and skincare chemists have been pushing for years. It's the first new sunscreen ingredient to clear US regulatory hurdles since the early 2000s, and it signals a major shift in how American sunscreens will feel on skin.
The approval matters because sunscreen is classified as a drug in the US, not a cosmetic product like it is in Europe and Asia. That classification triggers a lengthy approval process that has kept newer UV filters locked behind international borders while American consumers stuck with heavier formulas that pill under makeup, sting sensitive eyes, or leave white casts on darker skin.
Bemotrizinol, also called BEMT, is a broad-spectrum chemical filter that protects against both UVA rays (linked to aging and dark spots) and UVB rays (which cause sunburn). Both damage DNA and can lead to skin cancer. What sets it apart from current US options is its oil-soluble structure, which spreads easily and feels lightweight rather than greasy.
Joshua Zeichner, director of cosmetic and clinical research in dermatology at Mount Sinai Hospital, says BEMT offers superior UV protection to existing filters already approved here. More importantly, it opens the door to formulas that actually feel good to wear.
Cosmetic chemist Zobia Ahmed points out that people with medium to deeper skin tones stand to benefit most. BEMT creates more elegant finishes with fewer visible white casts than traditional chemical sunscreens. It also works well in hybrid mineral-chemical formulas, and can enable lightweight, even mattifying options for those with oily skin.
Because BEMT is generally well tolerated, dermatologist Marisa Garshick notes it should appeal to people with sensitive or reactive skin and those prone to eye irritation. Anyone who has used European sunscreen while traveling knows the texture difference between what's available there and what sits on American drugstore shelves. This approval could finally close that gap.
BEMT is already used in sunscreens abroad. Australia's Ultra Violette and Naked Sundays have been formulating with it for years, as have European brands like Eucerin, Nuxe, Bioderma, and Caudalie. Korean brands such as Beauty of Joseon and Purito also include it. The ingredient may also be listed on packaging as its scientific name, bis-ethylhexyloxyphenyl methoxyphenyl triazine.
US manufacturers can begin using BEMT as an active ingredient from August 9, 2026. Zeichner predicts leading brands including Neutrogena will launch new formulations later this year, though the exact products available abroad won't automatically appear in the US market right away.
On pricing, Ahmed expects BEMT won't dramatically shift sunscreen costs. It's a mid-to-premium ingredient, but final price depends on the entire formula, packaging, and brand positioning. Hello Sunday offers it at accessible price points, while luxury brands like Dior and Augustinus Bader do as well.
The broader impact hinges on a simple reality: sunscreen only works if people actually use it daily. The Skin Cancer Foundation reports nearly 90 percent of skin cancers link to sun exposure. When a better-feeling formula removes friction from the experience, it translates to better prevention.
Author Jessica Williams: "This is what happens when regulators finally listen to dermatologists and chemists pushing for innovation, and the timing couldn't be better for everyone tired of sunscreen that feels like a chore."
Comments